04/23/2024
3:36 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
4:06 PM | Shuttle Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/22/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
5:07 AM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
03/21/2024
4:28 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/14/2024
4:02 PM | Senanayake Chris (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:18 PM | Shuttle Pharmaceuticals (Issuer)
Vander Hoek Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/05/2024
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
7:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:05 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:10 PM | Brown Milton (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
8:51 PM | Jacobs Bette (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/30/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
4:14 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
3:10 PM | Shuttle Pharmaceuticals (Filer)
| Form DEF 14A | |
10/20/2023
3:15 PM | Shuttle Pharmaceuticals (Filer)
| Form ARS | |
10/10/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/05/2023
3:10 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
8:20 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/24/2023
1:00 PM | Shuttle Pharmaceuticals (Filer)
| Form 424B3 | |
08/18/2023
6:48 PM | Dritschilo Anatoly (Reporting)
Shuttle Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
5:30 AM | Shuttle Pharmaceuticals (Filer)
| Form DEF 14C | |
06/05/2023
7:10 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2023
4:30 PM | AFH Holding & Advisory, LLC (Filed by)
Shuttle Pharmaceuticals (Subject)
| Form SC 13G | |
05/26/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/25/2023
4:22 PM | Shuttle Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/17/2023
8:00 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:12 AM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
3:10 PM | Shuttle Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
